Feasibility study of maintenance therapy of TS-1 for stage IV non-small cell lung cancer

Feasibility study of maintenance therapy of TS-1 for stage IV non-small cell lung cancer - Feasibility study of maintenance TS-1 for non-small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004541

Enrollment

Registered

2010-11-11

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Histologically or cytologically proven stageIV non-small cell lung cancer. Patients previously treated with platinum- based chemotherapy and except PD cases by RECIST. Patients aged above 20 years. ECOG performance status (PS): 0-2 Patients having sufficient function of main organ and bone marrow. Written informed consent.

Exclusion criteria

Exclusion criteria: Patients with active interstitial pneumonia or pulmonary fibrosis recognized by chest X-ray. Patients with massive uncontrolled pleural effusion , ascites, or pericardial effusion. Patients having active other cancers. a serious or uncontrolled concomitant systematic disorder (ileus, interstitial pneumonia, pulmonary fibrosis, COPD, uncontrolled diabetes mellitus, cardiac infarction or unstable angina within 6 months.) Patients with active concomitant pregnancy. HIV or HBV-positive patients Inappropriate patients for this study judged by the physicians

Design outcomes

Primary

Measure	Time frame
To evaluate the feasibility of maintenance chemotherapy (TS-1)	—

Countries

Japan

Outcome results